Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Respiratory

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1642423

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1642423

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

PUBLISHED:
PAGES: 179 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.

Market Dynamics

Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.

Growth Drivers

Increasing Health Consciousness & Respiratory Conditions

  • A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
  • The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
  • Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.

Innovation & Expansion in Product Offerings

  • Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
  • The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
  • More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.

Business Opportunities

Development of Pediatric-Specific Products

  • Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
  • Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.

Demand for Natural & Herbal Cough Remedies

  • The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
  • Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.

Market Challenges

Regulatory Constraints

  • Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
  • Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.

Supply Chain Issues

  • Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
  • Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
  • Companies must adopt resilient supply chain strategies to maintain consistent distribution.

Regional Insights

Europe: Market Leader

  • The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
  • Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
  • A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.

South Asia & Pacific: Fastest-Growing Market

  • Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
  • Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
  • A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.

Leading Market Players

The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:

  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

Noteworthy Developments

New Product Introductions

  • 2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
  • Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.

Strategic Acquisitions

  • 2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
  • Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.

Market Segmentation

The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.

By Type:

  • Acute Cough
  • Chronic Cough

By Active Ingredients:

  • Dextromethorphan
  • Codeine
  • Butramirate
  • Benzonatate
  • Others

By Form:

  • Tablets/Capsules
  • Liquid Syrups
  • Sprays

By Sales Channels:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • E-commerce Platforms

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Cough Suppressant Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Cough Suppressant Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Cough Suppressant Market Outlook, 2019 - 2032

  • 4.1. Global Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Acute Cough
      • 4.1.1.2. Chronic Cough
  • 4.2. Global Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dextromethorphan
      • 4.2.1.2. Codeine
      • 4.2.1.3. Butramirate
      • 4.2.1.4. Bennzonatate
      • 4.2.1.5. Others
  • 4.3. Global Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Solid
      • 4.3.1.2. Liquid
      • 4.3.1.3. Spray
  • 4.4. Global Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Retail Pharmacies
      • 4.4.1.3. Drug Stores
      • 4.4.1.4. Online Pharmacies
  • 4.5. Global Cough Suppressant Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Cough Suppressant Market Outlook, 2019 - 2032

  • 5.1. North America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Acute Cough
      • 5.1.1.2. Chronic Cough
  • 5.2. North America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dextromethorphan
      • 5.2.1.2. Codeine
      • 5.2.1.3. Butramirate
      • 5.2.1.4. Bennzonatate
      • 5.2.1.5. Others
  • 5.3. North America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Solid
      • 5.3.1.2. Liquid
      • 5.3.1.3. Spray
  • 5.4. North America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Retail Pharmacies
      • 5.4.1.3. Drug Stores
      • 5.4.1.4. Online Pharmacies
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.2. U.S. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.3. U.S. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.4. U.S. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.5. Canada Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.6. Canada Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.7. Canada Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.8. Canada Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Cough Suppressant Market Outlook, 2019 - 2032

  • 6.1. Europe Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Acute Cough
      • 6.1.1.2. Chronic Cough
  • 6.2. Europe Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dextromethorphan
      • 6.2.1.2. Codeine
      • 6.2.1.3. Butramirate
      • 6.2.1.4. Bennzonatate
      • 6.2.1.5. Others
  • 6.3. Europe Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Solid
      • 6.3.1.2. Liquid
      • 6.3.1.3. Spray
  • 6.4. Europe Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Retail Pharmacies
      • 6.4.1.3. Drug Stores
      • 6.4.1.4. Online Pharmacies
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.2. Germany Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.3. Germany Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.4. Germany Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.5. U.K. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.6. U.K. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.7. U.K. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.8. U.K. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.9. France Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.10. France Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.11. France Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.12. France Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.13. Italy Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.14. Italy Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.15. Italy Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.16. Italy Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.17. Turkey Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.18. Turkey Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.19. Turkey Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.20. Turkey Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.21. Russia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.22. Russia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.23. Russia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.24. Russia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.25. Rest of Europe Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.26. Rest of Europe Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.27. Rest of Europe Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.28. Rest of Europe Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Cough Suppressant Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Acute Cough
      • 7.1.1.2. Chronic Cough
  • 7.2. Asia Pacific Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dextromethorphan
      • 7.2.1.2. Codeine
      • 7.2.1.3. Butramirate
      • 7.2.1.4. Bennzonatate
      • 7.2.1.5. Others
  • 7.3. Asia Pacific Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Solid
      • 7.3.1.2. Liquid
      • 7.3.1.3. Spray
  • 7.4. Asia Pacific Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Retail Pharmacies
      • 7.4.1.3. Drug Stores
      • 7.4.1.4. Online Pharmacies
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.2. China Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.3. China Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.4. China Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.5. Japan Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.6. Japan Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.7. Japan Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.8. Japan Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.9. South Korea Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.10. South Korea Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.11. South Korea Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.12. South Korea Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.13. India Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.14. India Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.15. India Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.16. India Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.17. Southeast Asia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.18. Southeast Asia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.19. Southeast Asia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.20. Southeast Asia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Cough Suppressant Market Outlook, 2019 - 2032

  • 8.1. Latin America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Acute Cough
      • 8.1.1.2. Chronic Cough
  • 8.2. Latin America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dextromethorphan
      • 8.2.1.2. Codeine
      • 8.2.1.3. Butramirate
      • 8.2.1.4. Bennzonatate
      • 8.2.1.5. Others
  • 8.3. Latin America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Solid
      • 8.3.1.2. Liquid
      • 8.3.1.3. Spray
  • 8.4. Latin America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Retail Pharmacies
      • 8.4.1.3. Drug Stores
      • 8.4.1.4. Online Pharmacies
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.2. Brazil Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.3. Brazil Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.4. Brazil Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.5. Mexico Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.6. Mexico Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.7. Mexico Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.8. Mexico Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.9. Argentina Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.10. Argentina Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.11. Argentina Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.12. Argentina Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Cough Suppressant Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Acute Cough
      • 9.1.1.2. Chronic Cough
  • 9.2. Middle East & Africa Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dextromethorphan
      • 9.2.1.2. Codeine
      • 9.2.1.3. Butramirate
      • 9.2.1.4. Bennzonatate
      • 9.2.1.5. Others
  • 9.3. Middle East & Africa Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Solid
      • 9.3.1.2. Liquid
      • 9.3.1.3. Spray
  • 9.4. Middle East & Africa Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Retail Pharmacies
      • 9.4.1.3. Drug Stores
      • 9.4.1.4. Online Pharmacies
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.2. GCC Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.3. GCC Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.4. GCC Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.5. South Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.6. South Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.7. South Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.8. South Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.9. Egypt Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.10. Egypt Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.11. Egypt Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.12. Egypt Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.13. Nigeria Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.14. Nigeria Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.15. Nigeria Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.16. Nigeria Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Type vs by Drugs Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Abbott Laboratories
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Acella Pharmaceuticals, LLC
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. GlaxoSmithKline Plc
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Johnson & Johnson services Inc.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Merck KGaA
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Novartis International AG
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Pfizer Inc.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Procter & Gamble
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!